Literature DB >> 33706757

Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics.

Pavel Dundr1, Naveena Singh2,3, Barbora Nožičková4, Kristýna Němejcová4, Michaela Bártů4, Ivana Stružinská4.   

Abstract

BACKGROUND: Making the distinction between primary mucinous and metastatic ovarian tumors is often difficult, especially in tumors with a primary source from the gastrointestinal tract, pancreas and biliary tree. The aim of the following paper is to provide an overview of the problematics, with a focus on the possibilities of the differential diagnosis at the macroscopic, microscopic and immunohistochemical level. MAIN BODY: The three main aspects of mucinous ovarian tumors are described in detail, including the comparison of the available diagnostic algorithms based on the evaluation of mostly macroscopic features, characterization of the spectrum of microscopic features, and a detailed analysis of the immunophenotype comparing 20 antibodies with the assessment of their statistical significance for differential diagnosis purposes. Specific features, including Krukenberg tumor and pseudomyxoma peritonei, are also discussed.
CONCLUSION: Despite the growing knowledge of the macroscopic and microscopic features of ovarian mucinous tumors and the availability of a wide range of immunohistochemical antibodies useful in this setting, there still remains a group of tumors which cannot be precisely classified without close clinical-pathological cooperation.

Entities:  

Keywords:  Mucinous borderline tumor; Mucinous carcinoma; Ovarian metastases; Ovarian tumors

Mesh:

Year:  2021        PMID: 33706757      PMCID: PMC7953678          DOI: 10.1186/s13000-021-01079-2

Source DB:  PubMed          Journal:  Diagn Pathol        ISSN: 1746-1596            Impact factor:   2.644


  130 in total

1.  Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms.

Authors:  Esther Elishaev; C Blake Gilks; Dianne Miller; Monica Srodon; Robert J Kurman; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2005-03       Impact factor: 6.394

Review 2.  SATB2 as an Immunohistochemical Marker for Colorectal Adenocarcinoma: A Concise Review of Benefits and Pitfalls.

Authors:  Kyra B Berg; David F Schaeffer
Journal:  Arch Pathol Lab Med       Date:  2017-10       Impact factor: 5.534

3.  Metastatic factors for Krukenberg tumor: a clinical study on 102 cases.

Authors:  Li Qiu; Ting Yang; Xue-Hua Shan; Ming-Bai Hu; Yan Li
Journal:  Med Oncol       Date:  2010-07-07       Impact factor: 3.064

4.  The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases.

Authors:  Kenneth R Lee; Robert H Young
Journal:  Am J Surg Pathol       Date:  2003-03       Impact factor: 6.394

5.  Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.

Authors:  Jesse K McKenney; Robert A Soslow; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2008-05       Impact factor: 6.394

6.  TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.

Authors:  Markus Rechsteiner; Anne-Katrin Zimmermann; Peter J Wild; Rosmarie Caduff; Adriana von Teichman; Daniel Fink; Holger Moch; Aurelia Noske
Journal:  Exp Mol Pathol       Date:  2013-08-18       Impact factor: 3.362

7.  Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis.

Authors:  Jeffrey D Seidman; Robert J Kurman; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2003-07       Impact factor: 6.394

8.  Secondary ovarian carcinoma: a clinical and pathological evaluation.

Authors:  R I Demopoulos; L Touger; N Dubin
Journal:  Int J Gynecol Pathol       Date:  1987       Impact factor: 2.762

9.  Krukenberg tumors of gastric origin versus colorectal origin.

Authors:  Yi Jo Jeung; Hee Jae Ok; Won Gyu Kim; Sung Han Kim; Tae Hwa Lee
Journal:  Obstet Gynecol Sci       Date:  2015-01-16

10.  Immunohistochemical expression of SMAD4, CK19, and CA19-9 in fine needle aspiration samples of pancreatic adenocarcinoma: Utility and potential role.

Authors:  Mauricio Zapata; Cynthia Cohen; Momin T Siddiqui
Journal:  Cytojournal       Date:  2007-06-22       Impact factor: 2.091

View more
  4 in total

1.  The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significance.

Authors:  Pavel Dundr; Barbora Bazalová; Michaela Bártů; Tjalling Bosse; Jana Drozenová; Pavel Fabian; Oluwole Fadare; Jitka Hausnerová; Radek Jakša; Jan Laco; Sigurd F Lax; Radoslav Matěj; W Glenn McCluggage; Gábor Méhes; Romana Michálková; Kristýna Němejcová; Naveena Singh; Simona Stolnicu; Petr Škapa; Marián Švajdler; Ivana Stružinská
Journal:  Virchows Arch       Date:  2022-05-13       Impact factor: 4.535

2.  Metastatic Ovarian Mucinous Carcinoma Presenting as Ileocecal Adenocarcinoma: A Case Report.

Authors:  Stephen E Glombicki; Diego Montelongo; Swethen Dushianthan; Camilo J Perez; Mario Cervantes; Alan P Glombicki
Journal:  Cureus       Date:  2022-04-29

3.  Isolated Ovarian Metastasis from Pancreatic Cancer Mimicking Primary Ovarian Neoplasia: Role of Molecular Analysis in Determining Diagnosis.

Authors:  Catherine M Tucker; Cheryl L Godcharles; Wei Jiang; Charles J Yeo; Norman G Rosenblum; Ethan J Halpern; William E Luginbuhl; Anthony J Prestipino
Journal:  J Pancreat Cancer       Date:  2021-10-14

4.  Misdiagnosed appendiceal mucinous neoplasms and primary ovarian mucinous tumors present with different pre- and intraoperative characteristics.

Authors:  Yi Yu; Tao Wang; Zhen Yuan; Wei Lin; Jiaxin Yang; Dongyan Cao
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.